However, the expression of another member of the serpin family, SERPINB3, together with a second proteinase inhibitor cystatin C, was demonstrated as independent predictors of response to platin-based chemotherapy in NSCLC [29]. The gene discussed is CST3; the disease is non-small cell lung carcinoma.